Clinical Trial Update: Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on lymphoscintigraphy-directed elective neck radiation for p16-positive favorable-risk oropharyngeal cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Oropharynx Cancer | Phase 2 | Status: RECRUITING